Article
The role of BRAF V600E mutation as a potential marker for prognostic stratification of papillary thyroid carcinoma: a long-term follow-up study.
Endocrine research - 1 Jan 2014
Daliri Mahdi, Abbaszadegan Mohammad Reza, Bahar Mostafa Mehrabi, Arabi Azadeh, Yadollahi Mona, Ghafari Azar, Taghehchian Negin, Zakavi Seyed Rasoul
Abstract excerpt
Abstract Papillary carcinoma is the most prevalent malignancy of thyroid gland, and its incidence has been recently increased. The BRAF(V600E) mutation is the most frequent genetic alteration in papillary thyroid carcinoma (PTC). The role of BRAF(V600E) mutation as a potential prognostic factor has been controversially reported in different studies, with short-term follow-up. In this study, we evaluated the role...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
